@cementokra0
Active 8 months, 4 weeks ago
OBJECTIVES To the best of our knowledge, data from Gemtuzumab ozogamicin in Acute Myeloid Leukemia (AML) patients with failure of organ functions and poor performance status are extremely lacking. Moreover, the fast recovery from organ failure, after Gemtuzumab ozogamicin administration, has never been reported. This study aimed to demonstrate […] View
Sorry, there was no activity found. Please try a different filter.